Archive

New study associates mask laws to reduction of COVID-19 deaths

Written by | 28 Dec 2021

Countries without face mask mandates experienced significantly higher COVID-19 deaths per million than countries that enacted mask mandates, investigators report in the American Journal of Preventive Medicine. A […]

Supermeres’ may carry clues to cancer, Alzheimer’s disease and COVID-19

Written by | 24 Dec 2021

Researchers at Vanderbilt University Medical Center have discovered a nanoparticle released from cells, called a “supermere,” which contains enzymes, proteins and RNA associated with multiple cancers, cardiovascular disease, […]

Molnupiravir – what you need to know

Written by | 10 Dec 2021

Molnupiravir has been approved by the MHRA for early treatment of mild-moderate covid-19 in vulnerable adults, it was announced on 4th November. It is good news that at […]

COVID-19 vaccination much more effective at preventing hospitalization than prior infection only

Written by | 18 Nov 2021

COVID-19 vaccination is about five times more effective at preventing COVID-related hospitalization than prior infection only, researchers reported on Oct. 29, 2021 in Morbidity and Mortality Weekly Report, […]

New findings on ambient UVB radiation, vitamin D, and protection against severe COVID-19

Written by | 1 Oct 2021

New research from Trinity College Dublin and University of Edinburgh has examined the association between vitamin D and COVID-19, and found that ambient ultraviolet B (UVB) radiation (which […]

Plant-based diet associated with lower risk of covid infection and less severe disease

Written by | 14 Sep 2021

In a recent study led by researchers at Massachusetts General Hospital (MGH) and Kings College Hospital published in Gut, people whose diets were based on healthy plant-based foods […]

EU approval boosts COVID vaccine manufacturing capacity

Written by | 5 Sep 2021

The European Medicines Agency (EMA) has approved additional manufacturing capacity for the Pfizer/BioNTech COVID-19 vaccine in France – increasing production by 51 million doses by the end of […]

Johnson & Johnson single-shot COVID-19 vaccine demonstrated a durable immune response and elicited dual mechanisms of protection against delta and other SARS-CoV-2 variants in data published in NEJM

Written by | 3 Aug 2021

Interim results from a Phase 1/IIa sub-study published in the New England Journal of Medicine (NEJM) demonstrated that both humoral (antibody) and cellular (T-cell) immune responses generated by […]

SARS-CoV-2 infection starts in nasal ciliated cells

Written by | 10 Jul 2021

Journal of Clinical Investigation The discovery that multiciliated cells in the nasal epithelium are the first cells to be targeted in early COVID-19 infection might provide the rationale […]

Antidepressant prescribing during covid-19

Written by | 2 Jul 2021

Some four million extra prescriptions for antidepressants were issued in 2020 compared to 2019 but the cost to the NHS increased by £139 million, according to a study published in […]

Mild COVID-19 induces lasting antibody protection, study finds

Written by | 4 Jun 2021

People who have had mild illness develop antibody-producing cells that can last lifetime Washington University School of Medicine Months after recovering from mild cases of COVID-19, people still […]

Pregnant women with COVID-19 face high mortality rate

Written by | 1 May 2021

In a worldwide study of 2,100 pregnant women, those who contracted COVID-19 during pregnancy were 20 times more likely to die than those who did not contract the […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.